Tumor cell-derived cathepsins B, L, and S were shown to play pivotal roles in facilitating reovirus-mediated oncolysis, as pretreatment with a specific inhibitor significantly delayed the cytotoxic effects of the virus in melanoma and glioblastoma cells. The gene discussed is CTSB; the disease is melanoma.